» Articles » PMID: 22860005

TMPRSS2- Driven ERG Expression in Vivo Increases Self-renewal and Maintains Expression in a Castration Resistant Subpopulation

Overview
Journal PLoS One
Date 2012 Aug 4
PMID 22860005
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Genomic rearrangements commonly occur in many types of cancers and often initiate or alter the progression of disease. Here we describe an in vivo mouse model that recapitulates the most frequent rearrangement in prostate cancer, the fusion of the promoter region of TMPRSS2 with the coding region of the transcription factor, ERG. A recombinant bacterial artificial chromosome including an extended TMPRSS2 promoter driving genomic ERG was constructed and used for transgenesis in mice. TMPRSS2-ERG expression was evaluated in tissue sections and FACS-fractionated prostate cell populations. In addition to the anticipated expression in luminal cells, TMPRSS2-ERG was similarly expressed in the Sca-1(hi)/EpCAM(+) basal/progenitor fraction, where expanded numbers of clonogenic self-renewing progenitors were found, as assayed by in vitro sphere formation. These clonogenic cells increased intrinsic self renewal in subsequent generations. In addition, ERG dependent self-renewal and invasion in vitro was demonstrated in prostate cell lines derived from the model. Clinical studies have suggested that the TMPRSS2-ERG translocation occurs early in prostate cancer development. In the model described here, the presence of the TMPRSS2-ERG fusion alone was not transforming but synergized with heterozygous Pten deletion to promote PIN. Taken together, these data suggest that one function of TMPRSS2-ERG is the expansion of self-renewing cells, which may serve as targets for subsequent mutations. Primary prostate epithelial cells demonstrated increased post transcriptional turnover of ERG compared to the TMPRSS2-ERG positive VCaP cell line, originally isolated from a prostate cancer metastasis. Finally, we determined that TMPRSS2-ERG expression occurred in both castration-sensitive and resistant prostate epithelial subpopulations, suggesting the existence of androgen-independent mechanisms of TMPRSS2 expression in prostate epithelium.

Citing Articles

ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity.

Feng W, Ladewig E, Salsabeel N, Zhao H, Lee Y, Gopalan A bioRxiv. 2024; .

PMID: 38585869 PMC: 10996491. DOI: 10.1101/2023.05.15.540839.


SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer.

Liao S, Rudoy D, Frank S, Phan L, Klezovitch O, Kwan J Nat Commun. 2023; 14(1):7435.

PMID: 37973913 PMC: 10654515. DOI: 10.1038/s41467-023-43245-8.


ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.

Li D, Zhan Y, Wang N, Tang F, Lee C, Bayshtok G Sci Adv. 2023; 9(14):eadc9446.

PMID: 37018402 PMC: 10075989. DOI: 10.1126/sciadv.adc9446.


TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence.

Fang L, Li D, Yin J, Pan H, Ye H, Bowman J Cancer Gene Ther. 2022; 29(10):1463-1476.

PMID: 35393570 PMC: 9537368. DOI: 10.1038/s41417-022-00454-5.


ETS factors in prostate cancer.

Qian C, Li D, Chen Y Cancer Lett. 2022; 530:181-189.

PMID: 35033589 PMC: 8832285. DOI: 10.1016/j.canlet.2022.01.009.


References
1.
Carver B, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A . Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet. 2009; 41(5):619-24. PMC: 2835150. DOI: 10.1038/ng.370. View

2.
Cai C, Wang H, Xu Y, Chen S, Balk S . Reactivation of androgen receptor-regulated TMPRSS2:ERG gene expression in castration-resistant prostate cancer. Cancer Res. 2009; 69(15):6027-32. PMC: 2859723. DOI: 10.1158/0008-5472.CAN-09-0395. View

3.
Zong Y, Xin L, Goldstein A, Lawson D, Teitell M, Witte O . ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proc Natl Acad Sci U S A. 2009; 106(30):12465-70. PMC: 2708977. DOI: 10.1073/pnas.0905931106. View

4.
Burger P, Xiong X, Coetzee S, Salm S, Moscatelli D, Goto K . Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A. 2005; 102(20):7180-5. PMC: 1129148. DOI: 10.1073/pnas.0502761102. View

5.
Owczarek C, Portbury K, Hardy M, OLeary D, Kudoh J, Shibuya K . Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. Gene. 2003; 324:65-77. DOI: 10.1016/j.gene.2003.09.047. View